In a statement, Amgen (AMGN -2%)
says that it does not expect any shortages of its medicines due to
COVID-19, adding that it is monitoring its raw material inventory levels
and is taking “additional measures” to mitigate against disruption.
https://seekingalpha.com/news/3549112-no-coronavirus-related-supply-problems-amgen
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.